Abbott Rapid Diagnostics A/S: Financial statements 2012
CVR: 24204650
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 31,967,019 and a net result of DKK 1,840,357. The profit margin was 5.8%. Equity in the 2012 report amounted to DKK -1,378,986. The company had 9 employees in the financial year.
- Revenue
- DKK 31,967,019
- Gross Profit
- DKK 7,646,389
- Profit/Loss
- DKK 1,840,357
- Equity
- DKK -1,378,986
- Total Assets
- DKK 40,764,969
- Employees
- 9
Official annual report
Keep an eye on Abbott Rapid Diagnostics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 9, 2012, Lise von Seelen has joined the board of directors of Abbott Rapid Diagnostics A/S.
As of August 9, 2012, Hilde Eylenbosch has joined the board of directors of Abbott Rapid Diagnostics A/S.
As of August 9, 2012, Martyn Robert Pither has joined the board of directors of Abbott Rapid Diagnostics A/S.
As of August 9, 2012, Véronique Yvonne Ameye has joined the board of directors of Abbott Rapid Diagnostics A/S.
As of August 9, 2012, Kari Stenersen has left the board of directors of Abbott Rapid Diagnostics A/S.
About Abbott Rapid Diagnostics A/S
Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.